{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:52:15Z","timestamp":1789501935151,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["01097\/2014-5"],"award-info":[{"award-number":["01097\/2014-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI16\/00903"],"award-info":[{"award-number":["PI16\/00903"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["RD12\/0042\/0037"],"award-info":[{"award-number":["RD12\/0042\/0037"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fsigenetics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International: Genetics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.fsigen.2019.07.010","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T11:40:36Z","timestamp":1563450036000},"page":"203-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths"],"prefix":"10.1016","volume":"42","author":[{"given":"M.","family":"Martinez-Matilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Blanco-Verea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Santori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ansede-Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ramos-Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AM.","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lotufo-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MH.","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Brisighelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Paramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Carracedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Brion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.fsigen.2019.07.010_bib0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1476-5381.2009.00487.x","article-title":"The thorough QT\/QTc study 4 years after the implementation of the ICH E14 guidance","volume":"159","author":"Darpo","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"202","key":"10.1016\/j.fsigen.2019.07.010_bib0010","article-title":"International conference on harmonisation; guidance on E14 clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs; availability. Notice","volume":"70","author":"H. Food","year":"2005","journal-title":"Fed. Regist."},{"issue":"9","key":"10.1016\/j.fsigen.2019.07.010_bib0015","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.hrthm.2009.07.002","article-title":"Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)","volume":"6","author":"Postema","year":"2009","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.fsigen.2019.07.010_bib0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.15420\/aer.2018.29.2","article-title":"Mechanisms underlying the actions of antidepressant and antipsychotic drugs that cause sudden cardiac arrest","volume":"7","author":"Sicouri","year":"2018","journal-title":"Arrhythm. Electrophysiol. Rev."},{"issue":"1","key":"10.1016\/j.fsigen.2019.07.010_bib0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/europace\/eut214","article-title":"Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany","volume":"16","author":"Sarganas","year":"2014","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.fsigen.2019.07.010_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14740338.7.2.181","article-title":"Sudden cardiac death secondary to antidepressant and antipsychotic drugs","volume":"7","author":"Sicouri","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.fsigen.2019.07.010_bib0035","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s11096-014-9953-6","article-title":"Frequency of use of QT-interval prolonging drugs in psychiatry in Belgium","volume":"36","author":"Vandael","year":"2014","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.fsigen.2019.07.010_bib0040","unstructured":"W.D.a.R.K. R.L. Woosley, C.W. Heise, T. Gallo, J. Tate, \u201cwww.CredibleMeds.org,\u201d [Online]. Available: https:\/\/crediblemeds.org\/."},{"issue":"10","key":"10.1016\/j.fsigen.2019.07.010_bib0045","doi-asserted-by":"crossref","first-page":"e016627","DOI":"10.1136\/bmjopen-2017-016627","article-title":"Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort","volume":"7","author":"Coughtrie","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.fsigen.2019.07.010_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/212178","article-title":"Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review","volume":"2012","author":"Kallergis","year":"2012","journal-title":"Sci. World J."},{"issue":"16","key":"10.1016\/j.fsigen.2019.07.010_bib0055","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.115.016217","article-title":"Molecular basis of hypokalemia-induced ventricular FibrillationCLINICAL PERSPECTIVE","volume":"132","author":"Pezhouman","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.fsigen.2019.07.010_bib0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cts.12393","article-title":"Pharmacological modulation of calcium homeostasis in familial dilated cardiomyopathy: an In vitro analysis from an RBM20 patient-derived iPSC model","volume":"9","author":"Wyles","year":"2016","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.fsigen.2019.07.010_bib0065","doi-asserted-by":"crossref","DOI":"10.1007\/s40264-015-0316-6","article-title":"Pharmacogenetics of drug-induced QT interval prolongation: an update","author":"Niemeijer","year":"2015","journal-title":"Drug Saf."},{"issue":"18","key":"10.1016\/j.fsigen.2019.07.010_bib0070","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/eurheartj\/ehv695","article-title":"The genetics underlying acquired long QT syndrome: impact for genetic screening","volume":"37","author":"Itoh","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.fsigen.2019.07.010_bib0075","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/europace\/euu288","article-title":"Multiplex ligation-dependent probe amplification copy number variant analysis in patients with acquired long QT syndrome","volume":"17","author":"Williams","year":"2015","journal-title":"Europace"},{"issue":"14","key":"10.1016\/j.fsigen.2019.07.010_bib0080","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jacc.2014.01.031","article-title":"Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome","volume":"63","author":"Weeke","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.fsigen.2019.07.010_bib0085","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000014448.19052.4C","article-title":"Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes","volume":"105","author":"Yang","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.fsigen.2019.07.010_bib0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1085\/jgp.96.1.195","article-title":"Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents","volume":"96","author":"Sanguinetti","year":"1990","journal-title":"J. Gen. Physiol."},{"issue":"5","key":"10.1016\/j.fsigen.2019.07.010_bib0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/74793","article-title":"A sensitive mechanism for cation modulation of potassium current","volume":"3","author":"Numaguchi","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.fsigen.2019.07.010_bib0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00232-013-9539-6","article-title":"Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor","volume":"246","author":"McBride","year":"2013","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.fsigen.2019.07.010_bib0105","first-page":"131","article-title":"CYP2D6 polymorphisms and their influence on risperidone treatment","volume":"9","author":"Puangpetch","year":"2016","journal-title":"Pers. Med."},{"issue":"2","key":"10.1016\/j.fsigen.2019.07.010_bib0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ccep.2016.02.003","article-title":"Pharmacogenetics of potassium channel blockers","volume":"8","author":"Roden","year":"2016","journal-title":"Card. Electrophysiol. Clin."},{"issue":"1","key":"10.1016\/j.fsigen.2019.07.010_bib0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2125.2000.00230.x","article-title":"CYP2D6 and CYP2C19 genotypes of patients with terodiline cardiotoxicity identified through the yellow card system","volume":"50","author":"Ford","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.fsigen.2019.07.010_bib0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/00450618.2011.620006","article-title":"Clarke\u2019s analysis of drugs and poisons. Fourth edition","volume":"44","author":"Kelly","year":"2012","journal-title":"Aust. J. Forensic Sci."},{"issue":"10","key":"10.1016\/j.fsigen.2019.07.010_bib0125","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/archdischild-2015-308200","article-title":"Broad-based molecular autopsy: a potential tool to investigate the involvement of subtle cardiac conditions in sudden unexpected death in infancy and early childhood","volume":"100","author":"Santori","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.fsigen.2019.07.010_bib0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.forsciint.2018.09.034","article-title":"Sudden unexpected death in the young \u2014 value of massive parallel sequencing in postmortem genetic analyses","volume":"293","author":"Scheiper","year":"2018","journal-title":"Forensic Sci. Int."},{"issue":"21-22","key":"10.1016\/j.fsigen.2019.07.010_bib0135","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1002\/elps.201400148","article-title":"Next generation sequencing challenges in the analysis of cardiac sudden death due to arrhythmogenic disorders","volume":"35","author":"Brion","year":"2014","journal-title":"ELECTROPHORESIS"},{"issue":"5","key":"10.1016\/j.fsigen.2019.07.010_bib0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"7616","key":"10.1016\/j.fsigen.2019.07.010_bib0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"7571","key":"10.1016\/j.fsigen.2019.07.010_bib0150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Gibbs","year":"2015","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.fsigen.2019.07.010_bib0155","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/bioinformatics\/btn241","article-title":"SNP analysis to results (SNPator): a web-based environment oriented to statistical genomics analyses upon SNP data","volume":"24","author":"Morcillo-Suarez","year":"2008","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.fsigen.2019.07.010_bib0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.clpt.6100406","article-title":"The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype","volume":"83","author":"Gaedigk","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.fsigen.2019.07.010_bib0165","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","article-title":"The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies","volume":"136","author":"Stenson","year":"2017","journal-title":"Hum. Genet."},{"issue":"44","key":"10.1016\/j.fsigen.2019.07.010_bib0170","first-page":"3925","article-title":"Modifier genes for sudden cardiac death","volume":"39","author":"Schwartz","year":"2018","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.fsigen.2019.07.010_bib0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00109-003-0522-z","article-title":"Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients","volume":"82","author":"Paulussen","year":"2004","journal-title":"J. Mol. Med."},{"issue":"1","key":"10.1016\/j.fsigen.2019.07.010_bib0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCGENETICS.111.960930","article-title":"A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes","volume":"5","author":"K\u00e4\u00e4b","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"9","key":"10.1016\/j.fsigen.2019.07.010_bib0185","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00228-016-2087-0","article-title":"Impact of age, gender and CYP2C9\/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid\u2014a large-scale study based on naturalistic therapeutic drug monitoring data","volume":"72","author":"Smith","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.fsigen.2019.07.010_bib0190","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.113.000239","article-title":"Slow delayed rectifier potassium current blockade contributes importantly to drug-induced long QT SyndromeClinical perspective","volume":"6","author":"Veerman","year":"2013","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"2","key":"10.1016\/j.fsigen.2019.07.010_bib0195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/cpt.205","article-title":"Late sodium current block for drug-induced long QT syndrome: results from a prospective clinical trial","volume":"99","author":"Johannesen","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.fsigen.2019.07.010_bib0200","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/jpet.117.246157","article-title":"Inhibition of the \u03b1-Subunit of phosphoinositide 3-Kinase in heart increases late sodium current and is arrhythmogenic","volume":"365","author":"Yang","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.fsigen.2019.07.010_bib0205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.forsciint.2014.01.014","article-title":"Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths","volume":"237","author":"Wang","year":"2014","journal-title":"Forensic Sci. Int."},{"issue":"8","key":"10.1016\/j.fsigen.2019.07.010_bib0210","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1172\/JCI25539","article-title":"Genetics of acquired long QT syndrome","volume":"115","author":"Roden","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.fsigen.2019.07.010_bib0215","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2018.01.030","article-title":"Cardiac genetic predisposition in sudden infant death syndrome","volume":"71","author":"Tester","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.fsigen.2019.07.010_bib0220","doi-asserted-by":"crossref","first-page":"e1003632","DOI":"10.1371\/journal.pgen.1003632","article-title":"Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease","volume":"9","author":"Lukas","year":"2013","journal-title":"PLoS Genet."},{"issue":"4","key":"10.1016\/j.fsigen.2019.07.010_bib0225","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12265-015-9624-6","article-title":"An investigation of the molecular mechanism of double cMyBP-C mutation in a patient with end-stage hypertrophic cardiomyopathy","volume":"8","author":"Gajendrarao","year":"2015","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"1","key":"10.1016\/j.fsigen.2019.07.010_bib0230","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1590\/S0066-782X2010000100004","article-title":"[Study of mutations causing hypertrophic cardiomyopathy in a group of patients from Espirito Santo, Brazil]","volume":"94","author":"Marsiglia","year":"2010","journal-title":"Arq. Bras. Cardiol."},{"issue":"9","key":"10.1016\/j.fsigen.2019.07.010_bib0235","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ejhg.2008.52","article-title":"Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations","volume":"16","author":"Frank-Hansen","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.fsigen.2019.07.010_bib0240","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0092-8674(01)00586-4","article-title":"The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation","volume":"107","author":"Davis","year":"2001","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.fsigen.2019.07.010_bib0245","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jacep.2018.09.010","article-title":"Plakophilin-2 truncation variants in patients clinically diagnosed with catecholaminergic polymorphic ventricular tachycardia and decedents with exercise-associated autopsy negative sudden unexplained death in the young","volume":"5","author":"Tester","year":"2019","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.fsigen.2019.07.010_bib0250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yjmcc.2013.07.011","article-title":"Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice","volume":"63","author":"St\u00f6hr","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"12","key":"10.1016\/j.fsigen.2019.07.010_bib0255","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCRESAHA.117.310083","article-title":"Calcium signaling and cardiac arrhythmias","volume":"120","author":"Landstrom","year":"2017","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.fsigen.2019.07.010_bib0260","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1113\/JP273047","article-title":"Linking myofilaments to sudden cardiac death: recent advances","volume":"595","author":"Huke","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.fsigen.2019.07.010_bib0265","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.forsciint.2015.07.052","article-title":"Mutations of desmoglein-2 in sudden death from arrhythmogenic right ventricular cardiomyopathy and sudden unexplained death","volume":"255","author":"Zhang","year":"2015","journal-title":"Forensic Sci. Int."},{"issue":"2","key":"10.1016\/j.fsigen.2019.07.010_bib0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/heart.88.2.153","article-title":"Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy","volume":"88","author":"Jouven","year":"2002","journal-title":"Heart (British Cardiac Society)"},{"issue":"1","key":"10.1016\/j.fsigen.2019.07.010_bib0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1542-474X.2008.00275.x","article-title":"M.-A. Kawashiri, H. Ino and M. Yamagishi, \u201cImpact of QT variables on clinical outcome of genotyped hypertrophic cardiomyopathy","volume":"14","author":"Uchiyama","year":"2009","journal-title":"Ann. Noninvasive Electrocardiol."},{"issue":"3","key":"10.1016\/j.fsigen.2019.07.010_bib0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCGENETICS.113.000362","article-title":"Abnormal cardiac formation in hypertrophic cardiomyopathy","volume":"7","author":"Captur","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"4","key":"10.1016\/j.fsigen.2019.07.010_bib0285","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/gim.2013.138","article-title":"Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment","volume":"16","author":"Das K","year":"2014","journal-title":"Genet. Med."},{"issue":"7","key":"10.1016\/j.fsigen.2019.07.010_bib0290","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMsa1507092","article-title":"Genetic misdiagnoses and the potential for health disparities","volume":"375","author":"Manrai","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fsigen.2019.07.010_bib0295","series-title":"Reassessment of Mendelian Gene Pathogenicity Using 7,855 Cardiomyopathy Cases and 60,706 Reference Samples","author":"Walsh","year":"2017"},{"issue":"7","key":"10.1016\/j.fsigen.2019.07.010_bib0300","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMra1710575","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.fsigen.2019.07.010_bib0305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajp.2015.06.001","article-title":"Venlafaxine induced QTc interval prolongation in a therapeutic dose","volume":"16","author":"Bavle","year":"2015","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.fsigen.2019.07.010_bib0310","first-page":"1","article-title":"Palpitations and asthenia associated with venlafaxine in a CYP2D6 poor metabolizer and CYP2C19 intermediate metabolizer","author":"Garcia","year":"2017","journal-title":"Case Rep. Genet."},{"issue":"6","key":"10.1016\/j.fsigen.2019.07.010_bib0315","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00008571-200208000-00008","article-title":"The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors","volume":"12","author":"Rasmussen","year":"2002","journal-title":"Pharmacogenetics"},{"issue":"9","key":"10.1016\/j.fsigen.2019.07.010_bib0320","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1517\/17425255.2013.795540","article-title":"Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia","volume":"9","author":"Perera","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."}],"container-title":["Forensic Science International: Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1872497319300778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1872497319300778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:02:31Z","timestamp":1761735751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1872497319300778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":64,"alternative-id":["S1872497319300778"],"URL":"https:\/\/doi.org\/10.1016\/j.fsigen.2019.07.010","relation":{},"ISSN":["1872-4973"],"issn-type":[{"value":"1872-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic susceptibility in pharmacodynamic and pharmacokinetic pathways underlying drug-induced arrhythmia and sudden unexplained deaths","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International: Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fsigen.2019.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}